Connect with us

Research

Walking performance may be early indicator of brain ageing – study

Published

on

Researchers believe that a decline in dual-task walking performance in middle age may be an early indicator of accelerated brain ageing and increased risk of falls and dementia.

Walking is a complex task that is most commonly performed while completing other tasks like talking, reading signs, or making decisions. 

For most, after the age of 65, such ‘dual tasking’ worsens walking performance and may even cause unsteadiness. Intriguingly, older adults that are more affected by dual tasking are at higher risk of suffering adverse health outcomes, including both falls and dementia.

A new research study published in Lancet Healthy Longevity has reported that the ability to dual task when walking starts to decline by the age of 55, up to a decade before ‘old age’ as traditionally-defined by the threshold of 65 years. 

What’s more, this decline in the ability to walk and talk at the same time was found to be caused not by changes in physical function, but instead by changes in cognition and underlying brain function.

Primary co-author of the study, Junhong Zhou, PhD, Assistant Scientist I, Hinda and Arthur Marcus Institute for Aging Research, explained: “Our results suggest that in middle age, poor dual task walking performance might be an indicator of accelerated brain ageing or an otherwise pre-symptomatic neurodegenerative condition.

“We assessed a large number of individuals between the ages of 40 and 64 years who are part of a study called the Barcelona Brain Health Initiative (BBHI). We observed that the ability to walk under normal, quiet conditions remained relatively stable across this age range. 

“However, even in this relatively healthy cohort, when we asked participants to walk and at the same time perform a mental arithmetic task, we were able to observe subtle yet important changes in gait starting in the middle of the sixth decade of life.”

 “This means that a simple test of dual task walking, which probes the brain’s ability to perform two tasks at the same time, can uncover early, age-related changes in brain function that may signify an increased risk of developing dementia in later life.”

The paper stemmed from a unique collaboration between researchers at the Hinda and Arthur Marcus Institute at Hebrew SeniorLife in Boston and the Guttmann Institut in Barcelona, Spain, where the population-based Barcelona Brain Health Initiative (BBHI) is being conducted. 

The Principal Investigator of the BBHI is Prof. David Batres-Faz from the University of Barcelona, and Dr. Alvaro Pascual-Leone, the medical director of the Deanna and Sidney Wolk Center for Memory Health, and a Senior Scientist at Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, and who serves as Scientific Director of the BBHI.

Zhou continued: “As compared to walking quietly, walking under dual task conditions adds stress to the motor control system because the two tasks (walking and mental arithmetic, for example) must compete for shared resources in the brain. What we believe is that the ability to handle this stress and adequately maintain performance in both tasks is a critical brain function that tends to be diminished in older age. Our study is important because it has discovered that changes in this type of brain resilience occur much earlier than previously believed.

He added: “Now, we have a clearer picture of age-related changes in the control of walking and how this relates to cognitive and brain health. 

“Importantly though, while we observed that dual task walking tended to diminish with advancing age across the entire cohort, not everyone in the study fit into this description. For example, we observed that a portion of participants over the age of 60 years who performed the dual task test as well as participants aged 50, or even younger. This means that dual task walking performance does not necessarily decline as we get older, and that some individuals appear more resistant to the effects of ageing. 

“We hope that our study will spur future research attempts to discover lifestyle and other modifiable factors that support the maintenance of dual task performance into old age, as well as interventions that target these factors.”

News

Finding could help identify diabetes patients at risk of vascular damage

Published

on

The longer someone has type 2 diabetes, the higher their cardiovascular disease risk, and changes in red blood cells may help explain it, new research suggests.

The study found red blood cells from patients with long-term diabetes harmed blood vessel function, while no such effect was seen in those newly diagnosed.

After seven years of follow-up, the blood cells of people initially diagnosed had developed the same harmful properties.

Zhichao Zhou, associate professor at Karolinska Institutet and lead author, said: “What really stands out in our study is that it is not only the presence of type 2 diabetes that matters, but how long you have had the disease.

“It is only after several years that red blood cells develop a harmful effect on blood vessels.”

Researchers at Karolinska Institutet in Sweden studied animals and patients with type 2 diabetes.

They identified microRNA-210, a small RNA that helps regulate gene activity, as a possible early biomarker of cardiovascular risk.

When its levels were restored in red blood cells, blood vessel function improved.

Eftychia Kontidou, doctoral student and first author, said: “If we can identify which patients are at greatest risk before vascular damage has already occurred, we can also become better at preventing complications.”

The researchers are now investigating whether the biomarker can be used in larger population studies.

Continue Reading

News

Routine vaccines may protect against dementia, research finds

Published

on

Routine vaccines for adults may reduce dementia risk, a review of more than 100 million people suggests.

The research found both flu and shingles vaccines were associated with a lower risk in adults aged 50 and over.

The shingles (herpes zoster) jab was linked to a 24 per cent lower risk of any dementia and a 47 per cent lower risk of Alzheimer’s disease.

A joint Italian-Canadian neuroscience review points to a pattern that public health experts say is hard to ignore, suggesting vaccines against common infections may offer long-term protection against the UK’s leading cause of death.

With an ageing population, about two million people are projected to be living with dementia in the UK by 2050.

Prof Sir Andrew Pollard is director of the Oxford Vaccine Group and former chair of the Joint Committee on Vaccination and Immunisation.

He said: “Vaccines for pneumonia, shingles, and influenza in older adults have been shown to reduce the risk of serious infections and hospitalisation caused by these diseases.

“But studies in the past few years have raised the intriguing possibility that vaccination could also provide a welcome reduction in the risk of dementia, a disease which places a huge burden on society and the NHS.”

A separate large-scale randomised trial in Wales compared shingles vaccines Zostavax and Shingrix to address the “healthy user effect”, where people who get vaccinated tend to be more health-conscious. As both groups were vaccinated, this helped control for that bias.

The results showed those receiving the newer Shingrix vaccine had a substantially lower risk of developing dementia over subsequent years.

Dr Maxime Taquet, clinical lecturer in psychiatry at Oxford, who led that study, said: “The size and nature of this study makes these findings convincing, and should motivate further research.”

Continue Reading

News

Weaker body clock linked to increased dementia risk

Published

on

Weaker, fragmented body clocks are linked to higher dementia risk, new research suggests.

The study also found that people whose activity levels peaked later in the day, rather than earlier, faced a higher risk.

Circadian rhythm is the body’s internal clock, regulating the 24-hour sleep-wake cycle and other processes including hormones, digestion and body temperature.

With a strong rhythm, the body clock aligns well with the 24-hour day, sending clear signals for body functions.

Researchers at UT Southwestern Medical Center in Texas studied 2,183 people with an average age of 79 who did not have dementia.

Participants wore small heart monitors for an average of 12 days to measure rest and activity patterns.

Over an average follow-up of three years, 176 people developed dementia. Those with weaker rhythms had nearly 2.5 times the risk of dementia compared to those with the strongest rhythms.

People whose activity peaked at 2.15pm or later had a 45 per cent increased risk compared to those peaking earlier in the afternoon.

Wendy Wang, the study author, said: “Changes in circadian rhythms happen with ageing, and evidence suggests that circadian rhythm disturbances may be a risk factor for neurodegenerative diseases like dementia.

“Disruptions in circadian rhythms may alter body processes like inflammation, and may interfere with sleep, possibly increasing amyloid plaques linked to dementia, or reducing amyloid clearance from the brain.

“Future studies should examine the potential role of circadian rhythm interventions, such as light therapy or lifestyle changes, to determine if they may help lower a person’s risk of dementia.”

Continue Reading

Trending

Agetech World